🔴 Critical Risk

MOVE: Movano Inc.
Dilution Risk Score 96/100

Movano Inc. (MOVE) carries a Critical dilution risk score of 96 out of 100 based on DilutionWatch's real-time analysis of SEC EDGAR filings. Contributing factors include warrants exceeding 312% of shares outstanding, convertible securities representing 386% of current share count, an active shelf registration for $1.0B.

Why MOVE Has a Critical Dilution Risk Score

DilutionWatch scores every ticker on a 0–100 scale by analyzing five components: cash runway, warrant overhang, convertible securities, active shelf/ATM capacity, and historical filing patterns. A score of 96 means MOVE is in the highest-risk category across multiple dimensions simultaneously.

• Cash runway: Estimated at 3.2 months — limited, increasing pressure to raise additional capital in the near term
• Warrant overhang: Outstanding warrants represent 312% of current shares outstanding — a massive potential dilution overhang if exercised
• Convertible securities: Convertible notes/instruments represent 386% of current shares — creating extreme dilution risk if converted
• Filing pattern: 5 dilutive filings in the past 12 months (last: 2026-02-12), indicating a pattern of repeat capital raises
• Active shelf registration: $1.0B registered for future sale — loaded and ready to execute

Recent SEC Filing History for MOVE

The following dilutive filings have been detected for MOVE in the past 12 months via DilutionWatch's real-time EDGAR monitoring:

How to Monitor MOVE for Dilution Alerts

DilutionWatch polls SEC EDGAR every 60 seconds. When Movano Inc. files an S-3, 424B, 8-K financing disclosure, or any of 25 tracked filing types, you receive an alert before the stock reprices. This is the same monitoring capability that institutional traders use — available to retail investors through DilutionWatch's free tier.

Additional Investor Analysis: MOVE Dilution Risk Insights

Historical Patterns for Retail Shareholders

A dilution risk score of 96/100 is extremely high and historically signals significant danger for retail investors. Companies with scores in this range often experience sharp declines in share price following major capital raises or warrant issuances. In past cases, such companies have seen average post-announcement price drops of 20–40%, especially when warrants are issued at prices well below market value. Retail shareholders who fail to act quickly during these periods often find themselves holding depreciated stock at a loss.

Key SEC Filings to Monitor

Investors tracking Movano Inc. should closely monitor the following filings on EDGAR:

• S-3 Registration Statement: Indicates potential shelf offerings that could dilute shares.
• 8-K Reports: Often contain announcements of new equity issuances, warrants, or PIPE deals.
• 424B5 Filings: Used for prospectus supplements related to securities offerings; critical for detecting upcoming dilution events.

These filings are crucial indicators of upcoming capital activity and can trigger immediate changes in dilution risk metrics.

DilutionScore vs. Sector Benchmarks

Movano Inc.’s 96/100 score places it well above the sector average for small-cap biotech and medical device companies, which typically range between 40–60 depending on market conditions. This elevated score suggests that MOVANO is facing far more aggressive capital-raising activity than its peers. Investors should use the to compare how this score stacks up against other stocks in similar sectors.

Next Steps for Monitoring Investors

For investors closely watching MOVE, immediate actions include:

• Regularly checking the Warrant Tracker for new warrant issuances.
• Monitoring the Shelf & ATM Monitor for signs of upcoming offerings.
• Using the DilutionWatch to track changes in dilution metrics over time.